Simcyp Simulator Demonstrates Bioequivalence (BE), Eliminating Need for Costly Clinical Study Case Study Simcyp™ Simulator 证明了生物等效性 (BE),无需进行昂贵的临床研究 In this case study, the sponsor’s closing of a manufacturing site required that one of…Certara2021 年 7 月 29 日
Maximizing oligonucleotide therapeutic development: Pre-clinical and translational considerations Blog Maximizing oligonucleotide therapeutic development: Pre-clinical and translational considerations This is the second of three blog posts discussing best practices for developing oligonucleotide therapeutics.…Certara2021 年 6 月 25 日
Drive Impactful Science from Bench to Market Brochure 推动具有影响力的科学成果从实验室走向市场 Learn how Certara drives impactful science.Certara2021 年 6 月 14 日
Your First Choice in Complex Biologics Drug Development Video Your First Choice in Complex Biologics Drug Development The pharmaceutical has made massive investments in complex biologics, a drug class that includes oligonucleotide…Certara2021 年 6 月 1 日
The Wizard of Oligos: There’s no place like having a successful drug development program! 网络研讨会点播 The Wizard of Oligos: There’s no place like having a successful drug development program! Oligonucleotide therapies— nucleic acid polymers with the potential to treat or manage a wide range…Certara2021 年 4 月 30 日
Certara (CERT) – Accelerating Medicines with Biosimulation Video Certara (CERT) – Accelerating Medicines with Biosimulation As seen on CNBC** Certara is the global leader in biosimulation, a powerful and proven…Certara2021 年 4 月 27 日
Part 3: Oligonucleotide therapeutic development: Clinical pharmacology considerations On-Demand Webinar 第 3 部分:Oligonucleotide therapeutic development: Clinical pharmacology considerations In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…Certara2021 年 4 月 21 日
Part 2: Oligonucleotide therapeutic development: Pre-clinical and translational considerations On-Demand Webinar 第 2 部分:Oligonucleotide therapeutic development: Pre-clinical and translational considerations In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…Certara2021 年 4 月 21 日
Part 1: What are oligonucleotide therapeutics, and how do they work? 网络研讨会点播 第 1 部分:What are oligonucleotide therapeutics, and how do they work? In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…Certara2021 年 4 月 21 日
Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure On-Demand Webinar Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure The European Medicines Agency (EMA) recently approved dulaglutide (Trulicity®) at higher doses (3 mg and…Certara2021 年 4 月 1 日